<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in 
PTEN-Null Glioma.

Heterotypic interactions across diverse cell types can enable tumor progression 
and hold the potential to expand therapeutic interventions. Here, combined 
profiling and functional studies of glioma cells in glioblastoma multiforme 
(GBM) models establish that PTEN deficiency activates YAP1, which directly 
upregulates lysyl oxidase (LOX) expression. Mechanistically, secreted LOX 
functions as a potent macrophage chemoattractant via activation of the β1 
integrin-PYK2 pathway in macrophages. These infiltrating macrophages secrete 
SPP1, which sustains glioma cell survival and stimulates angiogenesis. In 
PTEN-null GBM models, LOX inhibition markedly suppresses macrophage infiltration 
and tumor progression. Correspondingly, YAP1-LOX and β1 integrin-SPP1 signaling 
correlates positively with higher macrophage density and lower overall survival 
in GBM patients. This symbiotic glioma-macrophage interplay provides therapeutic 
targets specifically for PTEN-deficient GBM.]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P0" spans="709~718" text="PTEN-null" description="knock out" />
<PERTURBING_ACTION id="P1" spans="731~745" text="LOX inhibition" description="pharmacological inhibition" />
<CONTEXT id="C0" spans="719~729" text="GBM models" experiment_type="tumour" species="not stated" />
<CONTEXT id="C1" spans="766~776" text="macrophage" experiment_type="cells" species="not stated" />
</TAGS>
</Genomics_ConceptTask>